EMAIL THIS PAGE TO A FRIEND

Journal of chromatography. A

High-performance thin-layer chromatography screening of multi class antibiotics in animal food by bioluminescent bioautography and electrospray ionization mass spectrometry.


PMID 25015242

Abstract

The world-wide usage and partly abuse of veterinary antibiotics resulted in a pressing need to control residues in animal-derived foods. Large-scale screening for residues of antibiotics is typically performed by microbial agar diffusion tests. This work employing high-performance thin-layer chromatography (HPTLC) combined with bioautography and electrospray ionization mass spectrometry introduces a rapid and efficient method for a multi-class screening of antibiotic residues. The viability of the bioluminescent bacterium Aliivibrio fischeri to the studied antibiotics (16 species of 5 groups) was optimized on amino plates, enabling detection sensitivity down to the strictest maximum residue limits. The HPTLC method was developed not to separate the individual antibiotics, but for cleanup of sample extracts. The studied antibiotics either remained at the start zones (tetracyclines, aminoglycosides, fluoroquinolones, and macrolides) or migrated into the front (amphenicols), while interfering co-extracted matrix compounds were dispersed at hRf 20-80. Only after a few hours, the multi-sample plate image clearly revealed the presence or absence of antibiotic residues. Moreover, molecular information as to the suspected findings was rapidly achieved by HPTLC-mass spectrometry. Showing remarkable sensitivity and matrix-tolerance, the established method was successfully applied to milk and kidney samples.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

C1200000
Chloramphenicol, European Pharmacopoeia (EP) Reference Standard
C11H12Cl2N2O5
31667
Chloramphenicol, VETRANAL, analytical standard
C11H12Cl2N2O5
17776
Chlortetracycline Selective Supplement, for microbiology
C22H23ClN2O8
17850
Ciprofloxacin, ≥98.0% (HPLC)
C17H18FN3O3
PHR1167
Ciprofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
C17H18FN3O3
Y0000198
Ciprofloxacin, European Pharmacopoeia (EP) Reference Standard
C17H18FN3O3
17849
Enrofloxacin, ≥98.0% (HPLC)
C19H22FN3O3
33699
Enrofloxacin, VETRANAL, analytical standard
C19H22FN3O3
Y0001259
Enrofloxacin, European Pharmacopoeia (EP) Reference Standard
C19H22FN3O3
1235900
Enrofloxacin, United States Pharmacopeia (USP) Reference Standard
C19H22FN3O3
PHR1513
Enrofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
C19H22FN3O3
Y0001160
Enrofloxacin for system suitability, European Pharmacopoeia (EP) Reference Standard
C19H22FN3O3
E6376
Erythromycin, potency: ≥850 μg per mg
C37H67NO13
E5389
Erythromycin, BioReagent, suitable for cell culture
C37H67NO13
45674
Erythromycin, tested according to Ph.Eur.
C37H67NO13
PHR1039
Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material
C37H67NO13
E1300000
Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard
C37H67NO13
1242000
Erythromycin, United States Pharmacopeia (USP) Reference Standard
C37H67NO13
E0774
Erythromycin, meets USP testing specifications
C37H67NO13
E4514
Erythromycin, plant cell culture tested, ~98%
C37H67NO13
45703
Erythromycin standard solution, 1 mg/mL in H2O
C37H67NO13
34039
Marbofloxacin, VETRANAL, analytical standard
C17H19FN4O4
Y0000819
Marbofloxacin, European Pharmacopoeia (EP) Reference Standard
C17H19FN4O4
Y0000820
Marbofloxacin for peak identification, European Pharmacopoeia (EP) Reference Standard
C17H19FN4O4
51239
Oxytetra Selective Supplement, for microbiology
C22H24N2O9
1491004
Oxytetracycline, United States Pharmacopeia (USP) Reference Standard
C22H24N2O9 · 2H2O
PHR1537
Oxytetracycline, Pharmaceutical Secondary Standard; Certified Reference Material
C22H24N2O9 · 2H2O
S8626
Sulfadiazine, ≥99.0%
C10H10N4O2S
35033
Sulfadiazine, VETRANAL, analytical standard
C10H10N4O2S
1625009
Sulfadiazine, United States Pharmacopeia (USP) Reference Standard
C10H10N4O2S